Author
Listed:
- Monica E. D’Arcy
(National Cancer Institute
Rutgers Center for Pharmacoepidemiology and Treatment Sciences
Rutgers Cancer Institute)
- Ruth M. Pfeiffer
(National Cancer Institute)
- Marie C. Bradley
(National Cancer Institute)
- Phuc H. Hoang
(National Cancer Institute)
- Thi-Van-Trinh Tran
(National Cancer Institute)
- John P. McElderry
(National Cancer Institute)
- Mengying Li
(National Cancer Institute)
- Michael Kebede
(University of North Carolina)
- Curt T. DellaValle
(National Cancer Institute)
- Sara Rivas
(National Cancer Institute)
- Youjin Wang
(National Cancer Institute)
- Shahinaz M. Gadalla
(National Cancer Institute)
- Maria Teresa Landi
(National Cancer Institute)
Abstract
Lung cancer in never-smokers (LCINS) is a leading cause of cancer death globally, but no screening programs for LCINS exist. To identify medical conditions that could serve as markers of LCINS risk, we conducted a nested case-control study within the United Kingdom’s Clinical Practice Research Datalink (CPRD-GOLD), consisting of 1581 LCINS cases and 14,318 never-smoking controls. Conditions significantly associated with LCINS 1-10 years before the index date were validated in an independent dataset, CPRD-Aurum (2188 LCINS cases, 19,597 never-smoking controls). These conditions include Chronic Obstructive Pulmonary Disease/Emphysema (COPD); gastroesophageal reflux disease (GERD); bronchitis and tracheitis; diabetes mellitus type 1; and gastritis and non-infective gastroenteritis and colitis. Adjusting for medication use only slightly attenuated these associations. Overall, inflammatory diseases appear to be important in LCINS pathogenesis although further studies need to confirm these associations. Conditions such as GERD or COPD could be considered as part of eligibility criteria for future LCINS screening programs.
Suggested Citation
Monica E. D’Arcy & Ruth M. Pfeiffer & Marie C. Bradley & Phuc H. Hoang & Thi-Van-Trinh Tran & John P. McElderry & Mengying Li & Michael Kebede & Curt T. DellaValle & Sara Rivas & Youjin Wang & Shahina, 2025.
"Inflammatory diseases and risk of lung cancer among individuals who have never smoked,"
Nature Communications, Nature, vol. 16(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56803-z
DOI: 10.1038/s41467-025-56803-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56803-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.